SCHEMBL7967808

SCHEMBL7967808

CCCc1nc2c(NC(=O)c3ccc(C(=O)N(C)c4ccc(C)cc4OCCCCC(=C=O)N4CCN(C)CC4)cc3OC)cccc2[nH]1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 1/20 0.32
BRD4 O60885 1/20 0.32
HDAC4 P56524 1/20 0.32
HDAC1 Q13547 1/20 0.32
HDAC7 Q8WUI4 1/20 0.32
HDAC2 Q92769 1/20 0.32
HDAC10 Q969S8 1/20 0.32
HDAC11 Q96DB2 1/20 0.32
HDAC8 Q9BY41 1/20 0.32
HDAC6 Q9UBN7 1/20 0.32
HDAC9 Q9UKV0 1/20 0.32
HDAC5 Q9UQL6 1/20 0.32
MAP3K7 O43318 3/20 0.32
ABCB1 P08183 1/20 0.32
ABCG2 Q9UNQ0 1/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
ADORA2A P29274 1/20 0.31
ADORA2B P29275 1/20 0.31
ADORA1 P30542 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7968186 0.99 HDAC3 (0.32) HDAC3BRD4HDAC4HDAC1HDAC7
SCHEMBL7964677 0.95 HDAC3 (0.34) HDAC3BRD4HDAC4HDAC1HDAC7
SCHEMBL7480416 0.95 ABCB1 (0.34) HDAC3BRD4HDAC4HDAC1HDAC7
SCHEMBL7962042 0.95 HDAC3 (0.32) HDAC3BRD4HDAC4HDAC1HDAC7
SCHEMBL7955090 0.95 HDAC3 (0.32) HDAC3BRD4HDAC4HDAC1HDAC7
Hydrochloric Acid SCHEMBL7963051 0.95 HDAC3 (0.34) HDAC3BRD4HDAC4HDAC1HDAC7
Hydrochloric Acid SCHEMBL7966589 0.94 HDAC3 (0.32) HDAC3BRD4HDAC4HDAC1HDAC7
SCHEMBL7966817 0.94 HDAC3 (0.33) HDAC3BRD4HDAC4HDAC1HDAC7
SCHEMBL7966262 0.94 PTGES (0.37) PTGES
Hydrochloric Acid SCHEMBL7962708 0.93 PTGES (0.37) PTGES

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6316482-B1 FOR THERAPY AND PROPHYLAXIS OF HYPERTENSION, HEART FAILURE, RENAL INSUFFICIENCY, EDEMA, ASCITES, VASOPRESSIN PARASECRETION SYNDROME, HEPATOCIRRHOSIS, HYPONATREMIA, HYPOKALEMIA, DIABETIC, CIRCULATION DISORDER, CEREBROVASCULAR DISEASE FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-11-13 US disclosed